If you were a big pharma wanting the patches you would just wait and see if you can just get the IP cheapBig pharma hasn't wanted the patches in the last 8 or 10 years, why would they want it now? There is no IP, this company is now worthless.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game